On February 16, the U. S. District Court for the District of Oregon struck down the state’s drug price transparency law The Prescription Drug Price Transparency Act (the “Act”) ruling.
ACA International continues to monitor the COVID-19 situation on behalf of its members to ensure that we are providing the most up-to-date guidance and information to help you adapt to various, and often swift, changes. We are .